According to Sean Deveney of Heavy.com, Suns big man Deandre Ayton is scheduled to meet with the NBA by the end of this week to discuss his 25-game suspension for violating the terms of the NBA/NBPA Anti-Drug Program by testing positive for a diuretic.
Per Deveney’s league source, Ayton’s camp and the NBPA will present their case for a reduction of the suspension, arguing that Ayton ingested the banned diuretic by mistake.
[RELATED: Deandre Ayton Hit With 25-Game Suspension]
As we noted in our original piece regarding this story, part of the parties’ argument that the diuretic was taken unwittingly is based on Ayton’s drug test showing no traces of any other banned substances.
When asked yesterday if he had an update on the situation involving Ayton, Suns’ GM James Jones said the following:
“I don’t… that’s in the Player’s Association’s hands. We’re supporting Deandre. We’re focused on the team continuing to focus on the next game. That’ll take care of itself. I know he misses being out there with his teammates and whenever he comes back, we’ll be ready to re-integrate him and continue with this forward movement and momentum.”